N-linked glycans of the human insulin receptor and their distribution over the crystal structure

Proteins: Structure, Function and Genetics

Volumn 71, Issue 1, 2008, Pages 426-439

  Sparrow, Lindsay G ^a   Lawrence, Michael C ^a   Gorman, Jeffrey J ^a,b   Strike, Phillip M ^a   Robinson, Christine P ^a   McKern, Neil M ^a   Ward, Colin W ^a  

^a CSIRO   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Glycopeptides; Glycoprotein; Mass spectrometry; Molecular modelling; Three dimensional structure

Indexed keywords

AMINO ACID; BINDING PROTEIN; DIMER; GLYCAN DERIVATIVE; GLYCOPEPTIDE; GLYCOSYLATED PROTEIN; HUMAN INSULIN; IMMUNOGLOBULIN F(AB) FRAGMENT; INSULIN RECEPTOR; MANNOSE; PROTEINASE; RECEPTOR ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL LINE; CHEMICAL COMPOSITION; CHO CELL; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; ELECTRON; ENZYMATIC DEGRADATION; GLYCOSYLATION; HYBRID; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; RECEPTOR BINDING;

ANTIGENS, CD; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; GLYCOSYLATION; HUMANS; MASS SPECTROMETRY; POLYSACCHARIDES; RECEPTOR, INSULIN;

EID: 40549117199     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21768     Document Type: Article

References (48)

1. Sparrow LG, McKern NM, Gorman JJ, Strike PM, Robinson CP, Bentley JD, Ward CW. The disulfide bonds in the C-terminal domains of the human insulin receptor ectodomain. J Biol Chem 1997;272:29460-29467.
2. McKern NM, Lawrence MC, Streltsov VA, Lou M-Z, Adams TE, Lovrecz GO, Elleman TC, Richards KM, Bentley JD, Pilling PA, Hoyne PA, Cartledge KA, Pham TM, Lewis JL, Sankovich SE, Stoichevska V, Da Silva E, Robinson CP, Frenkel MJ, Sparrow LG, Fernley RT, Epa VC, Ward CW. Structure of the insulin receptor ectodomain homodimer reveals an unexpected folded-over conformation. Nature 2006;443:218-221.
3. Trombetta ES, Helenius A. Lectins as chaperones in glycoprotein folding. Curr Opin Struct Biol 1990;8:587-592.
4. Bass J, Chiu G, Argon Y, Steiner DF. Folding of insulin receptor monomers is facilitated by the molecular chaperones calnexin and calreticulin and impaired by rapid dimerization. J Cell Biol 1998;141:637-646.
5. Bass J, Steiner DF. Insulin receptor folding. In: Grunberger G, Zick Y, editors. Insulin signalling: from cultured cells to animal models. New York: Harwood Academic Press; 2000. pp 19-35.
6. Adams TE, Epa VC, Garrett TPJ, Ward CW. Structure and function of the type I insulin-like growth factor receptor. Cell Mol Life Sci 2000;57:1050-1093.
7. Elleman TC, Frenkel MJ, Hoyne PA, McKern NM, Adams TE, Jachno KM, Bentley JD, Sankovich SE, Ward CW. Mutational analysis of the N-linked glycosylation sites of the human insulin receptor. Biochem J 2000;347:771-779.
8. Sparrow LG, Gorman JJ, Strike PM, Robinson CP, McKern NM, Epa VC, Ward CW. The location and characterisation of the O-linked glycans of the human insulin receptor. Proteins: Struct Funct Bioinformatics 2006;66:261-265.
9. Deutscher SL, Hirschberg CB. Mechanism of galactosylation in the golgi apparatus. A Chinese hamster ovary cell mutant deficient in translocation of UDP-galactose across golgi vesicle membranes. J Biol Chem 1986;261:96-100.
10. Soos MA, Siddle K, Baron MD, Heward JM, Luzio JP, Bellatin J, Lennox ES. Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor. Biochem J 1986;235:199-208.
11. Dwek RA. Glycobiology: toward understanding the function of sugars. Chem Rev 1996;96:683-720.
12. Tulloch PA, Lawrence LJ, McKern NM, Robinson CP, Bentley JD, Cosgrove L, Robinson CP, Ivancic N, Siddle K, Ward CW. Single-molecule imaging of human insulin receptor ectodomain and its Fab complexes. J Struct Biol 1999;125:11-18.
13. Spellman MW, Basa LJ, Leonard CK, Chakel JA, O'Connor JV, Wilson S, van Halbeek H. Carbohydrate structures of human tissue plasminogen activator expressed in Chinese hamster ovary cells. J Biol Chem 1989;264:14100-14111.
14. Pitt JJ, Gorman JJ. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of sialylated glycopeptides and proteins using 2,6-dihydroxyacetophenone as a matrix. Rapid Commun Mass Spectrom 1996;10:1786-1788.
15. Pitt JJ, Gorman JJ. Oligosaccharide characterization and quantitation using 1-phenyl-3-methyl-5-pyrazolone derivatization and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Biochem 1997;248:63-75.
16. Lou M-Z, Garrett TPJ, Epa VC, McKern NM, Hoyne PA, Bentley JD, Lovrecz GO, Cosgrove LJ, Ward CW. Crystal structure of the first three domains of the human insulin receptor reveals major differences from the IGF-1 receptor in the regions governing ligand specificity. Proc Natl Acad Sci USA 2006;103:12429-12434.
17. Blanc E, Roversi P, Vonrhein C, Flensburg C, Lea SM, Bricogne G. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. Acta Crystallogr D Biol Crystallogr 2004;60:2210-2221.
18. Kraulis PJ. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 1991;24:946-950.
19. Lawrence MC, Bourke P. CONSCRIPT: a program for generating electron density isosurfaces from Fourier syntheses in protein crystallography. J Appl Crystallogr 2000;33:990-991.
20. Bohne-Lang A, von der Lieth CW. GlyProt: in silico glycosylation of proteins. Nucl Acids Res 2005;33 (Web Server Issue):W214-219.
21. Lütteke T, Bohne-Lang A, Loss A, Goetz T, Frank M, von der Lieth CW. GLYCOSCIENCES.de: an Internet portal to support glycomics and glycobiology research. Glycobiology 2006;16:71R-81R.
22. Lütteke T, Frank M, von der Lieth CW. Carbohydrate Structure Suite (CSS): analysis of carbohydrate 3D structures derived from the PDB. Nucleic Acids Res 2005;33 (Database Issue):D242-D246.
23. Jones TA, Zou JY, Cowan SW, Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 1991;47:110-119.
24. Connolly ML. Analytical molecular surface calculation. J Appl Crystallogr 1983;16:548-558.
25. Sanner MF, Olson AJ, Spehner JC. Reduced surface: an efficient way to compute molecular surfaces. Biopolymers 1996;38:305-320.
26. Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-Å resolution. Biochemistry 1981;20:2361-2370.
27. Harris LJ, Larson SB, Hasel KW, Day J, Greenwood A, McPherson A. The three-dimensional structure of an intact monoclonal antibody for canine lymphoma. Nature 1992;360:369-372.
28. Garrett TPJ, McKern NM, Lou M, Frenkel MJ, Bentley JD, Lovrecz GO, Elleman TC, Cosgrove L, Ward CW. Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Nature 1998;394:393-399.
29. Stura EA, Nemerow GR, Wilson IA. Strategies in the crystallization of glycoproteiens and protein complexes. J Cryst Growth 1992;122:273-285.
30. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998;393:648-659.
31. Baker HM, Day CL, Norris GE, Baker EN. Enzymatic deglycosylation as a tool for crystallization of mammalian binding proteins. Acta Crystallogr D Biol Crystallogr 1994;50:380-384.
32. Davis SJ, Puklavec MJ, Ashford DA, Harlos K, Jones EY; Stuart DI, Williams AF. Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2. Protein Eng 1993;6:229-232.
33. McKern NM, Lou M, Frenkel MJ, Verkuylen A, Bentley JD, Lovrecz GO, Ivancic N, Elleman TC, Garrett TPJ, Cosgrove L, Ward CW. Crystallization of the first three domains of the human insulin-like growth factor-1 receptor. Protein Sci 1997;6:2663-2666.
34. Sacher M, Di Bacco A, Lunin W, Ye Z, Wagner J, Gill G, Cygler M. The crystal structure of CREG, a secreted glycoprotein involved in cellular growth and differentiation. Proc Natl Acad Sci USA 2005;102:18326-18331.
35. Ruf W, Stura EA, LaPolla RJ, Syed R, Edgington TS, Wilson IA. Purification, sequence and crystallization of an anti-tissue factor Fab and its use for the crystallization of tissue factor. J Cryst Growth 1992;122:253-264.
36. Rudd PM, Dwek RA. Glycosylation: heterogeneity and the 3D structure of proteins. Crit Rev Biochem Mol Biol 1997;32:1-100.
37. Cosgrove L, Lovrecz GO, Verkuylen A, Cavaleri L, Black LA, Bentley JD, Howlett GJ, Gray P, Ward CW. Purification and properties of insulin receptor ectodomain from large-scale mammalian cell culture. Protein Expr Purif 1995;6:789-798.
38. Hoyne PA, Cosgrove LJ, McKern NM, Bentley JD, Ivancic N, Elleman TC, Ward CW. High affinity insulin binding by soluble insulin receptor extracellular domain fused to a leucine zipper. FEBS Lett 2000;479:15-18.
39. Haniu M, Arakawa T, Bures EJ, Young Y, Hui JO, Rohde MF, Welcher AA, Horan T. Human leptin receptor. Determination of disulfide structure and N-glycosylation sites of the extracellular domain. J Biol Chem 1998;273:28691-28699.
40. Stenflo J, Fernlund P. Amino acid sequence of the heavy chain of bovine protein C. J Biol Chem 1982;257:12180-12190.
41. Miletich JP, Broze GJ, Jr. Beta protein C is not glycosylated at asparagine 329. The rate of translation may influence the frequency of usage at asparagine-X-cysteine sites. J Biol Chem 1990;265:11397-11404.
42. Titani K, Kimar S, Takio K, Ericsson LH, Wade RD, Ashida K, Walsh KA, Chopek MW, Sadler JE, Fujikawa K. Amino acid sequence of human von Willebrand factor. Biochemistry 1986;25:3171-3184.
43. Sato C, Kim JH, Abe Y, Saito K, Yokoyama S, Kohda D. Characterization of the N-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor. J Biochem (Tokyo). 2000;127:65-72.
44. Mir-Shekari SY, Ashford DA, Harvey DJ, Dwek RA, Schulze IT. The glycosylation of the influenza A virus hemagglutinin by mammalian cells. A site-specific study. J Biol Chem 1997;272:4027-4036.
45. Silverman J, Liu Q, Bakker A, To W, Duguay A, Alba BM, Smith R, Rivas A, Li P, Le H, Whitehorn E, Moore KW, Swimmer C, Perlroth V, Vogt M, Kolkman J, Stemmer WP. Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains. Nat Biotechnol 2005;23:1556-1561.
46. Binz HK Amstutz P, Pluckthun A. Engineering novel binding proteins from nonimmunoglobulin domains. Nat Biotechnol 2005;23:1257-1268.
47. Schlehuber S, Skerra A. Lipocalins in drug discovery: from natural ligand-binding proteins to 'anticalins'. Drug Discov Today 2005;10:23-33.
48. Ulrich H. RNA aptamers: from basic science towards therapy. Handb Exp Pharmacol 2006;173:305-326.